Coagulation management in Massive bleeding

Current Opinion in Anaesthesiology

Volumn 23, Issue 2, 2010, Pages 263-268

  Griffee, Matthew J ^a   DeLoughery, Thomas G ^b   Thorborg, Per A ^a  

^a Department of Anesthesiology and Perioperative Medicine ^*  (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acute coagulopathy of trauma; Damage control resuscitation; Massive transfusion protocol; Prothrombin complex concentrate; Recombinant factor VIIa

Indexed keywords

FRESH FROZEN PLASMA; HEPARIN; PLACEBO; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; WARFARIN;

ACUTE DISEASE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL PROTOCOL; CLINICAL TRIAL; ERYTHROCYTE CONCENTRATE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INJURY; MORTALITY; NONHUMAN; PLASMA TRANSFUSION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SHOCK; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOGENICITY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; COAGULANTS; FACTOR VIIA; HEMATOCRIT; HEMORRHAGE; HEMOSTATICS; HOMEOSTASIS; HUMANS; MILITARY MEDICINE; PLASMA; RECOMBINANT PROTEINS; RESUSCITATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 77952159558     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32833723fe     Document Type: Review

References (48)

1. Hess JR, Dutton RB, Holcomb JB, Scalea TM. Giving plasma at a 1:1 ratio with red cells in resuscitation: who might benefit? Transfusion 2008;48:1763-1765.
2. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003;54:1127-1130.
3. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: •• hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008;64:1211-1217. This investigation clarifies the mechanism of acute coagulopathy of trauma in patients without coagulation factor loss or dysfunction and suggests novel targets for treatment.
4. Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and • packed red blood cells in the first 6 h of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009;197:565-570. A multicenter database analysis of 466 massively transfused patients demonstrating the early separation of survival curves in patients with high FFP:PRBC and platelet: PRBC ratios.
5. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008;248:447-458.
6. Advanced trauma life support for doctors. 2nd ed. Chicago, IL: American College of Surgeons; 1997.
7. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007;245:812-818.
8. Lier H, Krep H, Schoechl H. Coagulation management in the treatment of multiple trauma. Anesthetist 2009;58:1010-1026.
9. Mosnier LO, Gale AJ, Yegneswaran S, Griffin JH. Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. Blood 2004;104:1740-1744.
10. Cannon W, Frawer J, Cowell E. The preventive treatment of wound shock. JAMA 1918;70:618-621.
11. Beekley AC. Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med 2008;36(Suppl): S267-S274.
12. Scalea TM, Bochicchio KM, Lumpkins K, et al. Early aggressive use of fresh • frozen plasma does not improve outcomes in critically injured trauma patients. Ann Surg 2008;248:578-584. Thoughtful analysis of potential reasons for conflicting civilian and military data regarding transfusion practices.
13. Snyder CW, Weinberg JA, McGwin G, et al. The relationship of blood product •• ratio to mortality: survival benefit or survival bias? J Trauma 2009;66:358-364. This study demonstrates the relevance of correcting for survival benefit in analyses of cohorts of patients with massive bleeding. All subsequent clinical research on this question must include the statistical correction described in this paper.
14. Riskin DJ, Tsai TC, Riskin L, et al. Massive transfusion protocols: the role of •• aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009;209:198-205. This study provides insight into one of the main functions of a MTP: reducing the time from ordering blood to starting the transfusion. This improvement led to markedly improved survival, without any change in the FFP:PRBC ratio.
15. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to • red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008;248:447-458. This study includes detailed discussion of principles of hemostatic resuscitation.
16. Zink KA, Sambasivan CN, Holcomb JB, et al. A high ratio of plasma and platelets to packed red blood cells in the first 6 h of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009;197:565-570.
17. Cotton BA, Guy JS, Morris JA Jr, et al. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006;26:115-121.
18. Kiraly LN, Differding JA, Enomoto TM, et al. Resuscitation with normal saline vs. lactated ringers modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic swine model. J Trauma 2006;61:57-65.
19. Deb S, Sun L, Martin B, et al. Lactated ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma 2000;49:47-55.
20. Maegele M, Lefering R, Paffrath T, et al. Red blood cell to plasma ratios • transfused during massive transfusion are associated with mortality in severe multiply [sic] injury. Vox Sang 2008;95:112-119. This study presents data from 497 patients, using a registry comprising 30% of trauma patients in Germany.
21. Watson GA, Sperry JL, Rosengart MR, et al. Fresh frozen plasma is inde- • pendently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009;67:221-230. This article reports data on patients with blunt injury. Considering the lack of mortality benefit and the increased riskof multiorgan failure or acute lung injury with every unit of FFP, this report highlights the need to define the population who will benefit from hemostatic resuscitation.
22. Nakazawa H, Ohnishi H, Okazaki H, et al. Impact of fresh-frozen plasma from male-only donors versus mixed-sex donors on postoperative respiratory function in surgical patients: a prospective case-controlled study. Transfusion 2009;49:2434-2441.
23. Goris RJ. Pathophysiology of shock in trauma. Eur J Surg 2000;166:100-111.
24. O'Keefe T, Refaai M, Tchorz K, et al. A massive transfusion protocol to decrease blood component use and costs. Arch Surg 2008;143:686-691.
25. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and •• coagulopathy are sustained better in patients with blunttrauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 2009;66:1616-1624. This study exemplifies the effect of a protocol on resuscitation, with decreased early crystalloid use, increased FFP, and improved mortality.
26. Shuja F, Shults C, Duggan M, et al. Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2008;65:975-985.
27. Vigue B. Bench-to-bedside review: optimizing emergency reversal of vitamin K • antagonists in severe haemorrhage - from theory to practice. Crit Care 2009;13:209-218. Excellent overview of the advantages of factor concentrate over FFP.
28. Bruce D, Nokes T J C. Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit Care 2008;12: R105. (doi:10.1186/cc6987).
29. Rahe-Meyer N, Solomon C, Winterhalter M, et al. Thromboelastometry-guided • administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aneurysm surgery. J Thorac Cardiovasc Surg 2009;138:694-702. Tantalizing pilot study of an immediate benefit of using fibrinogen concentrate for complex surgery, with sustained, reduced bleeding over 24 h.
30. Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009;102:785-792.
31. Velik-Salchner C, Haas T, Innerhofer P, et al. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007;5:1019-1025.
32. Heindl B, Delorenzo C, Spannagl M. High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthetist 2005;54:787-790.
33. Weinkove R, Rangarajan S. Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfus Med 2008;18:151-157.
34. Danes AF, Cuenca LG, Bueno SR, et al. Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sang 2008;94:221-226.
35. Haas T, Fries D, Velik-Salchner C, et al. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008;106:725-731.
36. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105:905-91 7.
37. Dawes R, Thomas G O R. Battlefield resuscitation. Curr Opin Crit Care 2009; •• 15:527-535. This is a state-of-the art review of the multipronged technique of treating massive hemorrhage in young, otherwise healthy patients with severe injuries. Many of the strategies described in this review are currently being studied in the context of clinical trials or animal models.
38. Duchesne JC, Mathew KA, Marr AB, et al. Current evidence based guidelines for factor VIIa use in trauma: the good, the bad, and the ugly. Am Surg 2008;74:1159-1165.
39. Berkhof FF, Eikenboom J C J. Efficacy of recombinant activated factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis. Transfusion 2009;49:570-577.
40. Perkins JG, Schreiber MA, Wade CE, Holcomb JB. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma 2007;62:1095-1099.
41. Dutton R, Hauser C, Boffard K, et al. Scientific and logistical challenges in •• designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding. Clin Trials 2009;6:467-479. An important analysis of the difficulty of studying a patient population with lifethreatening injuries who require emergency interventions. This analysis should aid investigators in designing future studies.
42. Spinella PC, Perkins JG, Grathwohl KW. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009;66(4 Suppl): S69-76.
43. Roberts I. The CRASH-2 trial of an antifibrinolytic agent in traumatic haemorrhage: an international collaboration. Indian J Med Res 2007;125:5-7.
44. Alam HB, Bice LM, Butt MU, et al. Testing of blood products in a polytrauma model: results of a multiinstitutional randomized preclinical trial. J Trauma 2009;67:856-864.
45. Yao L, Kuai J, Liu X. Pretreatment with fentanyl and propofol attenuates myocardial injury in rabbits with acute hemorrhagic shock. J Surg Res 2009;155:25-31.
46. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and thromboelastometry in assessing coagulopathy of trauma. Scand J Trauma Resusc Emerg Med 2009;17:45.
47. Johansson PI, Stensballe J. Effect of hemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 2009;96:111-118.
48. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. Br J Obstet Gynaecol 2009;116:1097-1102.